Rapid Micro Biosystems (RPID) Accumulated Expenses (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Accumulated Expenses data on file, last reported at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 29.02% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (up 29.02% YoY), and the FY2025 full-year result was $8.3 million, up 15.23% from the prior year.
• Accumulated Expenses declined to $6.5 million in Q1 2026, from $8.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9.9 million in Q4 2023 to a low of $2.3 million in Q2 2022.
• A 5-year average of $6.6 million and a median of $7.0 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 231.11% in 2023 and dropped 28.59% in 2025, its largest moves.
• Tracing RPID's Accumulated Expenses over 5 years: stood at $8.2 million in 2022, then increased by 21.56% to $9.9 million in 2023, then retreated by 27.15% to $7.2 million in 2024, then advanced by 15.23% to $8.3 million in 2025, then declined by 21.9% to $6.5 million in 2026.
• Business Quant data shows RPID's Accumulated Expenses at $6.5 million in Q1 2026, $8.3 million in Q4 2025, and $6.6 million in Q3 2025.